Study guide
6.3 PALS Assessment, CPR & Cardiac Arrest
NBRC RRT-NPS Neonatal/Pediatric Specialist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Neonatal and Pediatric Patient Assessment
1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage
2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring
2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics
3 Chapter 3: Airway Management & Secretion Clearance
3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning
4 Chapter 4: Pharmacology & Medical Gas Therapy
4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation
5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders
5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration
6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety
6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care
7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation
7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk
8 Chapter 8: High-Frequency Ventilation & Advanced Modes
8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure
9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy
9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response
10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness
10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains
11 Chapter 11: Congenital Heart Disease & Hemodynamic Management
11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS
12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care
12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation
6.3 PALS Assessment, CPR & Cardiac Arrest
Key Takeaways Explain This Topic AI
High-quality pediatric CPR requires a compression rate of 100 to 120/min, a depth of at least 1/3 the AP chest diameter (~1.5 inches in infants, ~2 inches in children), complete chest recoil, and a 15:2 compression-to-ventilation ratio for two healthcare rescuers (30:2 for single rescuer).
For pediatric cardiac arrest with shockable rhythms (VF/pulseless VT), deliver an initial defibrillation shock of 2 J/kg, a second shock of 4 J/kg, and subsequent shocks ≥4 J/kg (maximum 10 J/kg or 200 J biphasic), administering Epinephrine 0.01 mg/kg every 3–5 minutes after the second shock and Amiodarone 5 mg/kg (or Lidocaine 1 mg/kg) for refractory VF/pVT.
Symptomatic pediatric bradycardia with cardiopulmonary compromise (HR <60 bpm with poor perfusion despite adequate oxygenation and ventilation) mandates immediate chest compressions; administer Epinephrine 0.01 mg/kg (0.1 mL/kg of 0.1 mg/mL), reserving Atropine 0.02 mg/kg (minimum 0.1 mg) for increased vagal tone or primary AV block.
Last updated: September 2026
6.3 PALS Assessment, CPR & Cardiac Arrest
Pediatric cardiac arrest commonly follows progressive respiratory failure or shock, although primary arrhythmia, congenital heart disease, myocarditis, trauma, toxins, and sudden collapse also occur. The American Heart Association (AHA) Pediatric Advanced Life Support (PALS) guidelines emphasize early recognition, rapid physiologic stabilization, high-quality cardiopulmonary resuscitation (CPR), and prompt reversal of hypoxemia and acidosis before irreversible ischemic arrest occurs.
PALS Systematic Approach: Evaluate, Identify, Intervene
The PALS framework consists of a continuous, iterative cycle: Evaluate → \rightarrow → Identify → \rightarrow → Intervene . [Initial Assessment: Pediatric Assessment Triangle (PAT)]
- Appearance | Work of Breathing | Circulation to Skin
- │
- ▼
- [Primary Assessment: ABCDE Sequence]
- Airway | Breathing | Circulation | Disability | Exposure
- │
- ▼
- [Secondary Assessment & Diagnostics]
- Focused SAMPLE History & Targeted Lab/Radiographic Studies
- 1. Pediatric Assessment Triangle (PAT)
A rapid 30-second observational assessment conducted without touching the child:
Appearance: Tone, interactiveness, consolability, look/gaze, speech/cry (reflects central nervous system oxygenation and perfusion).
Work of Breathing: Tachypnea, retractions, nasal flaring, head bobbing, grunting, stridor, wheezing.
Circulation to Skin: Pallor, mottling, cyanosis, petechiae.
2. Primary Assessment (ABCDE)
Airway: Patent, maintainable with simple positioning (sniffing position, jaw thrust), or unmaintainable (requires advanced airway).
Breathing: Respiratory rate, air entry, chest expansion, breath sounds, S p O 2 SpO_2 Sp O 2 , transcutaneous or end-tidal C O 2 CO_2 C O 2 .
Circulation: Heart rate, central vs. peripheral pulses, capillary refill time ( < 2 seconds <2\text{ seconds} < 2 seconds is normal), skin temperature, systemic blood pressure.
Hypotension Thresholds by Age (Systolic BP):
- Term Neonates (0–28 days): < 60 mmHg <60\text{ mmHg} < 60 mmHg
- Infants (1–12 months): < 70 mmHg <70\text{ mmHg} < 70 mmHg
Children (1–10 years): < 70 + ( 2 × Age in years ) mmHg <70 + (2 \times \text{Age in years})\text{ mmHg} < 70 + ( 2 × Age in years ) mmHg
Children > 10 >10 > 10 years: < 90 mmHg <90\text{ mmHg} < 90 mmHg
Disability: Neurological status using the AVPU scale (Alert, Voice, Pain, Unresponsive) or Glasgow Coma Scale (GCS), pupil size and reactivity, and bedside blood glucose (rule out hypoglycemia).
Exposure: Undress patient to inspect for trauma, rashes, purpura fulminans (meningococcemia), and monitor core body temperature.
Pediatric High-Quality CPR Metrics
High-quality CPR is the cornerstone of pediatric resuscitation, maximizing coronary and cerebral perfusion pressures.
Core CPR Performance Metrics
Compression Rate: 100 to 120 compressions/min across all pediatric age groups.
Compression Depth:
Infants (<1 year): At least one-third (1/3) the AP diameter of the chest , approximately 1.5 inches (4 cm) .
Children (1 year to puberty): At least one-third (1/3) the AP diameter of the chest , approximately 2.0 inches (5 cm) .
Adolescents: Adult depth of 2.0 to 2.4 inches (5 to 6 cm) .
Recoil: Allow full chest wall recoil after each compression; do not lean on the chest. Incomplete recoil increases intrathoracic pressure, impeding venous return and decreasing cardiac output.
Minimize Interruptions: Keep pauses in compressions to < 10 seconds (e.g., for rhythm checks or defibrillation).
Compression-to-Ventilation Ratios:
Single Rescuer: 30:2 .
Two Healthcare Rescuers: 15:2 .
Advanced Airway in Place (ETT or Supraglottic Airway): Deliver continuous chest compressions without pauses for breaths, providing 1 breath every 2 to 3 seconds (20 to 30 breaths/min) .
Avoid Excessive Ventilation: Hyperventilation increases intrathoracic pressure, decreases venous return, reduces cardiac output, and induces cerebral vasoconstriction via hypocarbia.
Pediatric Cardiac Arrest: Shockable vs. Non-Shockable Algorithms
When a pediatric patient has no central pulse or signs of life, CPR is initiated immediately and the monitor/defibrillator is attached to identify the cardiac rhythm.
Table 6.3.1: Pediatric Cardiac Arrest Management: Shockable vs. Non-Shockable
- Clinical Parameter Shockable Rhythms (VF / Pulseless VT) Non-Shockable Rhythms (PEA / Asystole)
- Incidence in Pediatrics 10% – 15% of initial pediatric arrests 85% – 90% of pediatric arrests (predominant)
Primary Etiology Congenital heart disease, myocarditis, toxic ingestions, channelopathies, commotio cordis Severe hypoxemia, asphyxia, respiratory failure, end-stage septic or hypovolemic shock
Defibrillation Dosing Initial Shock: 2 J/kg; Second Shock: 4 J/kg; Subsequent Shocks: ≥ 4 J/kg \ge 4\text{ J/kg} ≥ 4 J/kg (max 10 J/kg or 200 J) Contraindicated. Defibrillation provides no benefit and causes myocardial necrosis.
Epinephrine Administration 0.01 mg/kg IV/IO (0.1 mL/kg of 0.1 mg/mL) after 2nd shock , repeated every 3–5 min 0.01 mg/kg IV/IO (0.1 mL/kg of 0.1 mg/mL) ASAP , repeated every 3–5 min
Antiarrhythmic Therapy Amiodarone: 5 mg/kg IV/IO bolus (max 3 doses) OR Lidocaine: 1 mg/kg IV/IO loading dose None. Focus entirely on high-quality CPR and reversing underlying H's and T's.
Reversible Causes (H's & T's) Hypoxia, Hydrogen ion (acidosis), Hyperkalemia, Hypothermia, Toxins Hypovolemia, Hypoxia, Hydrogen ion, Hypo/Hyperkalemia, Hypothermia, Hypoglycemia, Tension pneumothorax, Tamponade, Toxins, Thrombosis
Defibrillation Sequence for VF / Pulseless VT
Deliver Shock 1 (2 J/kg) unsynchronized. Immediately resume CPR for 2 minutes without checking rhythm or pulse.
Rhythm check: If persistent VF/pVT, deliver Shock 2 (4 J/kg) . Resume CPR immediately. Administer Epinephrine 0.01 mg/kg IV/IO and consider advanced airway placement.
Rhythm check: If persistent VF/pVT, deliver Shock 3 ( ≥ 4 J/kg \ge 4\text{ J/kg} ≥ 4 J/kg , up to 10 J/kg) . Resume CPR immediately. Administer Amiodarone 5 mg/kg IV/IO bolus (or Lidocaine 1 mg/kg).
Pediatric Bradycardia with Cardiopulmonary Compromise
Bradycardia in children is most frequently caused by progressive tissue hypoxia, acidosis, and hypothermia .
The Critical Clinical Threshold: HR < 60 bpm
If a child has a heart rate < 60 beats/min <60\text{ beats/min} < 60 beats/min with signs of poor perfusion (altered mental status, weak central pulses, absent peripheral pulses, hypotension, delayed capillary refill) despite effective oxygenation and ventilation:
MANDATORY PALS INTERVENTION: INITIATE CHEST COMPRESSIONS IMMEDIATELY!
Major NBRC Testing Principle: Do not wait for complete asystole. In pediatrics, symptomatic bradycardia with hypoperfusion is treated as functional cardiac arrest.
Pharmacologic Interventions in Bradycardia
Epinephrine (First-Line):
Dose: 0.01 mg/kg IV/IO ( 0.1 mL/kg 0.1\text{ mL/kg} 0.1 mL/kg of 0.1 mg/mL formulation). Repeat every 3 to 5 minutes. Stimulates β 1 \beta_1 β 1 -adrenergic receptors to increase chronotropy and inotropy, and α 1 \alpha_1 α 1 -receptors to increase systemic vascular resistance.
Atropine Sulfate:
Dose: 0.02 mg/kg IV/IO (minimum single dose 0.1 mg ; maximum single dose 0.5 mg in children, 1.0 mg in adolescents). May repeat once.
Specific Indications: Reserved for bradycardia resulting from increased vagal tone (e.g., during laryngoscopy, suctioning, or carotid sinus stimulation), organophosphate toxicity, or primary atrioventricular (AV) conduction block.
NPS Exam Caution: Doses < 0.1 mg <0.1\text{ mg} < 0.1 mg can precipitate paradoxical central vagal stimulation, worsening the bradycardia.
Emergency Transthoracic / Transcutaneous Pacing: Indicated for bradycardia unresponsive to medical therapy due to congenital heart disease, surgical complete heart block, or intrinsic nodal pathology.